PLoSONE 12(9):e0184986.https://doi.org/10.1371/journal.pone.0184986
On the road to ending TB
Highlights from the 30 highest TB burden countries
Tackling Tuberculosis in Under-Served Populations: A Resource for TB Control Boards and their partners
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...duce HIV-related morbidity and mortality. Further, co-trimoxazole is an off-patent drug and widely available in resource-limited settings.
more
Meeting report, 25-26 September 2017 Copenhagen, Denmark
Participant Manual September 2009
Copenhagen, Denmark, 24–25 August 2017
PLOS ONE | www.plosone.org
September 2014 | Volume 9 | Issue 9 | e103657
A survey of prevention, testing and treatment policies and practices
Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The targets of 80% reduction in TB incidence rate and 90% reduction in TB mortality by 2030 (compared to 2015 levels) can be achieved only with addition...al interventions aimed at preventing TB, according to epidemiological modelling studies commissioned by the WHO South-East Asia Regional Office (WHO SEARO). Optimal implementation of TB preventive treatment (TPT) is a critical intervention to accelerate reduction in TB burden in the SEA Region, which bears nearly 43% of the global TB burden. TPT by itself has the potential to reduce the overall annual TB incidence rates by 8.3% (95% CrI 6.5–10.8) relative to 2015.
more
Blueprint for EECA countries, first edition